García Salcedo, José Antonio Author
Serum osteoprotegerin: bone or cardiovascular marker in Type 2 diabetes males?
- Rozas Moreno P
- Reyes García R
- García-Martín A
- Varsavsky M
- García-Salcedo JA
- Muñoz-Torres M
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION - 1/01/2013
- SJR Quartile: Q2
- JCR Impact Factor: 1.552 (2013)
- CiteScore: 6.1 (2020)
- SJR: 0.614 (2013
- SNIP: 0.686 (2013
- JCR 5-year Impact Factor: 1.615
- JCR Categories: ENDOCRINOLOGY & METABOLISM
- SJR Categories: Endocrinology, Diabetes and Metabolism (Q2); Endocrinology (Q3)
- Scopus
- ORCID
- Web of Science
Relationchips between taxonomy and function of microorganisms in natural environments
- Miralles-Mellado, I.
- Millan-Casamayor, V.
- Garcia-Salcedo, J. A.
- Leiros de la Pena, M. del Carmen
- Trasar-Cepeda, C.
- Soriano, M.
- Pastor, F. M. -A.
- Gil-Sotres, F.
FEBS Journal - 09/2012
- JCR Quartile: Q2 (2012)
- SJR Quartile: Q1
- JCR Impact Factor: 4.25 (2012)
- JCR 5-year Impact Factor: 3.6
- JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
- SJR Categories: Biochemistry (Q1); Molecular Biology (Q1); Cell Biology (Q2)
Characterization of actin nucleating Arp2/3 complex in Trypanosoma brucei
- Pena, J. M.
- Rubotham, J.
- Morales, S.
- Nolan, D.
- Garcia-Salcedo, J. A.
FEBS Journal - 09/2012
- SJR Quartile: Q1
- JCR Impact Factor: 4.25 (2012)
- JCR 5-year Impact Factor: 3.6
- JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
- SJR Categories: Biochemistry (Q1); Molecular Biology (Q1); Cell Biology (Q2)
Sclerostin serum levels are increased in prostate cancer patients
- Garcia-Fontana, B.
- Morales, S.
- Varsaysky, M.
- Garcia-Martin, A.
- Garcia-Salcedo, J. A.
- Reyes-Garcia, R.
- Munoz-Torres, M.
BONE - 05/2012
10.1016/j.bone.2012.02.572 View source
- SJR Quartile: Q1
- JCR Impact Factor: 3.823 (2012)
- JCR 5-year Impact Factor: 4.247
- JCR Categories: ENDOCRINOLOGY & METABOLISM
- SJR Categories: Endocrinology, Diabetes and Metabolism (Q1); Histology (Q1); Physiology (Q1)
Increasing levels of serum sclerostin, an osteocyte-expressed negative regulator of bone formation, are associated with atherosclerotic disease in type 2 diabetes
- Morales, S.
- Garcia-Fontana, B.
- Garcia-Martin, A.
- Rozas-Moreno, P.
- Garcia-Salcedo, J. A.
- Reyes-Garcia, R.
- Munoz-Torres, M.
BONE - 05/2012
10.1016/j.bone.2012.02.552 View source
- SJR Quartile: Q1
- JCR Impact Factor: 3.823 (2012)
- JCR 5-year Impact Factor: 4.247
- JCR Categories: ENDOCRINOLOGY & METABOLISM
- SJR Categories: Endocrinology, Diabetes and Metabolism (Q1); Histology (Q1); Physiology (Q1)
Relationship between serum levels of osteocalcin and atherosclerotic disease in type 2 diabetes.
- Reyes-Garcia R
- Rozas-Moreno P
- Jimenez-Moleon JJ
- Villoslada MJ
- Garcia-Salcedo JA
- Santana-Morales S
- Muñoz-Torres M
DIABETES and METABOLISM - 1/02/2012
- SJR Quartile: Q1
- JCR Impact Factor: 2.388 (2012)
- CiteScore: 8.4 (2020)
- SJR: 1.071 (2012
- SNIP: 1.135 (2012
- JCR 5-year Impact Factor: 2.856
- JCR Categories: ENDOCRINOLOGY & METABOLISM
- SJR Categories: Internal Medicine (Q1); Medicine (miscellaneous) (Q1); Endocrinology (Q2); Endocrinology, Diabetes and Metabolism (Q2)
- Scopus
- ORCID
- Web of Science
Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus.
- García-Martín A
- Rozas-Moreno P
- Reyes-García R
- Morales-Santana S
- García-Fontana B
- García-Salcedo JA
- Muñoz-Torres M
JOURNAL OF CLINICAL ENDOCRINOLOGY and METABOLISM - 1/01/2012
- SJR Quartile: Q1
- JCR Impact Factor: 6.43 (2012)
- CiteScore: 8.5 (2020)
- SJR: 3.107 (2012
- SNIP: 2.391 (2012
- JCR 5-year Impact Factor: 6.568
- JCR Categories: ENDOCRINOLOGY & METABOLISM
- SJR Categories: Biochemistry (Q1); Biochemistry (medical) (Q1); Clinical Biochemistry (Q1); Endocrinology (Q1); Endocrinology, Diabetes and Metabolism (Q1); Medicine (miscellaneous) (Q1)
- Scopus
- ORCID
- Web of Science
[Pentosidine: a new biomarker in diabetes mellitus complications].
- Morales S
- García-Salcedo JA
- Muñoz-Torres M
MEDICINA CLINICA - 19/03/2011
- SJR Quartile: Q3
- JCR Impact Factor: 1.385 (2011)
- CiteScore: 1.4 (2020)
- SJR: 0.243 (2011
- SNIP: 0.435 (2011
- JCR 5-year Impact Factor: 1.243
- JCR Categories: MEDICINE, GENERAL & INTERNAL
- SJR Categories: Medicine (miscellaneous) (Q3)
- Scopus
- ORCID
- Web of Science
Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappa B in women with postmenopausal osteoporosis
- Reyes-García R.
- Muñoz-Torres M.
- García D.
- Mezquita-Raya P.
- García Salcedo J.
- De Dios Luna J.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY - 1/1/2010
- SJR Quartile: Q1
- JCR Impact Factor: 3.318 (2010)
- CiteScore: 4.7 (2020)
- SJR: 1.311 (2010
- SNIP: 1.115 (2010
- JCR 5-year Impact Factor: 3.474
- JCR Categories: OBSTETRICS & GYNECOLOGY
- SJR Categories: Obstetrics and Gynecology (Q1)
Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death.
- Delgado M
- Anderson P
- Garcia-Salcedo JA
- Caro M
- Gonzalez-Rey E
CELL DEATH AND DIFFERENTIATION - 1/03/2009
- SJR Quartile: Q1
- JCR Impact Factor: 8.24 (2009)
- CiteScore: 18.8 (2020)
- SJR: 5.862 (2009
- SNIP: 1.844 (2009
- JCR 5-year Impact Factor: 8.387
- JCR Categories: CELL BIOLOGY
- SJR Categories: Cell Biology (Q1); Molecular Biology (Q1)
- Scopus
- ORCID
- Web of Science
Progress towards new treatments for human African trypanosomiasis
- Garcia-Salcedo J.
- Munday J.
- Unciti-Broceta J.
- De Koning H.
Trypanosomes and Trypanosomiasis - 1/4/2014
Complications During Clinical Evolution in Lung Transplantation: Pulmonary Embolism
- Garcia-Salcedo, J. A.
- de la Torre, M. M.
- Delgado, M.
- Paradela, M.
- Fieira, E. M.
- Gonzalez, D.
- Fernandez, R.
- Borro, J. M.
TRANSPLANTATION PROCEEDINGS - 10/2010
10.1016/j.transproceed.2010.05.063 View source
- SJR Quartile: Q2
- JCR Impact Factor: 0.993 (2010)
- JCR 5-year Impact Factor: 1.046
- JCR Categories: IMMUNOLOGY
- SJR Categories: Surgery (Q2); Transplantation (Q3)
This author has no patents.
Erratum: Targeting ribosomal G-quadruplexes with naphthalene-diimides as RNA polymerase I inhibitors for colorectal cancer treatment (Cell Chemical Biology (2021) 28(11) (1590–1601.e4), (S245194562100266X), (10.1016/j.chembiol.2021.05.021))
- Sanchez-Martin V.
- Schneider D.A.
- Ortiz-Gonzalez M.
- Soriano-Lerma A.
- Linde-Rodriguez A.
- Perez-Carrasco V.
- Gutierrez-Fernandez J.
- Cuadros M.
- Morales J.C.
- González C.
- Soriano M.
- Garcia-Salcedo J.A.
Cell Chemical Biology - 16/12/2021
10.1016/j.chembiol.2021.12.007
- JCR Impact Factor: 9.039 (2021)
- CiteScore: 12.9 (2020)
- SJR: 3.364 (2020
- SNIP: 1.698 (2020
- JCR 5-year Impact Factor: 9.198
- JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
Contact info
Email: jags@genyo.es
h index
Scopus: 16
Web of Science: 19
i10 index
Scopus: 23
Web of Science: 32
Research groups
-
Salud y medio ambiente
Role: Miembro
Author profiles
-
ORCID
-
Scopus Author ID
-
Dialnet id
Research projects at UAL
-
Acronym PID2020-120481RB-I00Since: September 1, 2021Until: August 31, 2024Funded by: MECFunding / grant amount: 85,000.00 EURRole: Equipo de trabajo